CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 181 enrolled
Drug / intervention
Azithromycin +3 moredrug
Likely dose
Azithromycin 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02756403
NCT02756403N/ACompleted

A Randomized Controlled Trial of Three Prophylactic Antibiotic Regimens for First Trimester Surgical Abortion

Medstar Health Research Institute·interventional·Posted Apr 29, 2016·Updated Feb 11, 2022

In Brief

A clinical study evaluating Azithromycin, Doxycycline, and 2 other interventions for First Trimester Abortion. Completed, enrolled 181 participants across 2 sites.

Detailed Summary

This study, a double blinded randomized controlled trial, is being done to compare side effects of commonly used antibiotic regimens prior to same day abortion procedures. In total, 180 pregnant women in their first trimester of pregnancy (5 0/6-13 6/7 weeks gestation) will be randomized to receive one of the three commonly used antibiotics (azithromycin, doxycycline, metronidazole) for same day abortion procedures or placebo prior to their abortion procedure. Approximately, 30-60 mins after study drug administration, the procedure will be performed. A sub-study will be completed on 40 women who consent to endometrial sampling and to have their blood drawn.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 29, 2016
Enrollment StartMar 1, 2016
Primary CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.2 years ago

Interventions

Azithromycindrug

500 mg

Doxycyclinedrug

200 mg

Metronidazoledrug

500 mg

Placebodrug

Placebo pills will be given before the uterine aspiration. Antibiotics will be given after the uterine aspiration.